Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
7 drugs for “Major Depressive Disorder”
Approved 2
- CariprazineAbbVie Inc.Major Depressive Disorder
- LumateperoneIntra-Cellular Therapies, Inc.Major Depressive Disorder
Phase 3 5
- AzetukalnerXenon Pharmaceuticals Inc.Major Depressive Disorder
- DT120Definium Therapeutics, Inc.Major Depressive Disorder
- NBI-1065845NEUROCRINE BIOSCIENCES INCMajor Depressive Disorder
- NMRA-335140Neumora Therapeutics, Inc.Major Depressive Disorder
- OsavampatorNEUROCRINE BIOSCIENCES INCMajor Depressive Disorder
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.